• SENSEX 78,094.64
    166.49 (+0.21%)
  • BANKNIFTY 57,264.85
    117.35 (+0.21%)
  • Bajaj Finance
    1,151.20 1,151.20(%)
  • Torrent Pharma.
    5,139.30 5,139.30(%)
  • Netweb Technol.
    4,597.95 5,241.65(%)
  • TVS Motor Co.
    4,320.00 4,320.00(%)
  • Rossell Techsys
    979.95 1,111.00(%)
  • Indo-MIM
    815.90 815.90(%)
  • Kaynes Tech
    3,860.55 7,705.00(%)
  • Hero Motocorp
    5,397.80 6,390.00(%)
  • 63 Moons Tech.
    949.65 1,029.35(%)
  • Adani Ports
    1,707.00 1,891.80(%)
  • Shadowfax Technologies
    253.35 253.35(%)
  • Kalyan Jewellers
    610.15 327.15(%)
  • M & M
    3,456.00 3,840.00(%)
  • Tata Motors
    440.40 508.95(%)
  • HFCL
    194.30 229.40(%)
  • Hyundai Motor I
    2,208.90 2,889.65(%)
  • Swiggy
    280.00 235.85(%)
  • TBO Tek
    1,565.80 1,764.00(%)
  • Reliance Industries
    1,309.30 1,611.20(%)
  • Eicher Motors
    7,795.00 5,390.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lasa Supergenerics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 67941.0
  • ISIN : INE670X01014
6.87 0 (-1.58%)
  • As on 01 Aug 2026 (EOD)

  • Today’s Low

    6.80

  • Today’s High

    7.14

  • Open

    6.81

  • Perv Close

    6.98

  • 52W Low

    5.67

  • 52W High

    14.08

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    34.42

  • Div & Yield %

    0.00

  • Book Value(₹)

    9.90

  • Debt-Equity Ratio

    -1.58

  • AGM Date

    31-Jul-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    34.42

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    50.10

  • BV (₹)

    9.90

  • Sales( ₹ in Cr.)

    25.14

  • NP (in Cr.)

    -13.05

  • NP Var(%)

    -1532.0

  • Div%

    0.0

  • CPS (₹)

    -1.40

  • EPS (₹)

    -2.60

  • Traded Value (₹ in Lakhs)

    34.82

  • 52 Week High

    14.08

  • 52 Week Low

    5.67

  • Price BSE

    7.0

  • Price NSE

    7.00

  • Market Capital( in Cr.)

    34.82

  • P/C Ratio

    -5.00

  • P/E Ratio

    -2.70

  • Price Vs.BV

    -2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 142.45 104.34 129.57 137.13 202.38 167.27
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.01
Net Sales 142.45 104.34 129.57 137.13 202.38 167.26
Other Income 5.01 0.10 1.80 0.27 0.06 0.23
Stock Adjustments 1.91 4.06 4.01 3.17 -10.24 -7.65
Total Income 149.37 108.50 135.38 140.57 192.20 159.84
EXPENDITURE :            
Raw Materials 108.10 79.28 110.12 94.46 102.11 87.01
Power and Fuel Cost 0.00 7.45 7.72 7.06 8.06 7.92
Employee Cost 6.11 5.37 6.35 7.15 14.01 13.42
Other Manufacturing Expenses 0.00 8.02 6.24 5.36 9.94 7.95
Selling and Administration Expenses 0.00 5.64 6.98 9.03 9.72 6.54
Miscellaneous Expenses 39.56 9.19 22.63 9.07 0.98 6.82
Employee Benefit Expenses 6.11 5.37 6.35 7.15 14.01 13.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 153.76 114.95 160.03 132.13 144.82 129.65
Operating Profit -4.39 -6.45 -24.66 8.43 47.38 30.20
Interest 2.69 1.99 4.19 0.06 2.06 8.12
Gross Profit -7.08 -8.44 -28.85 8.37 45.32 22.08
Depreciation 12.30 10.67 13.42 14.51 15.82 17.34
Profit Before Tax -19.38 -19.11 -42.27 -6.14 29.50 4.74
Current Tax 0.00 0.00 0.04 0.65 1.07 1.28
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -4.63 2.62 -3.69 -1.46 5.65 -0.17
Reported Net Profit -14.76 -21.73 -38.62 -5.33 22.78 3.63
Extraordinary Items -15.67 -7.57 -19.22 -7.79 -0.01 -0.17
Adjusted Net Profit 0.91 -14.16 -19.40 2.46 22.79 3.80
Adjustment below Net Profit 0.04 0.12 0.04 0.06 -5.33 0.04
P & L Balance brought forward -46.98 -25.37 14.23 20.52 3.28 -0.39
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 1.02 1.02 0.00 0.00
P & L Balance carried down -61.69 -46.98 -25.37 14.23 20.73 3.28
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 2.50 2.50 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.25 0.25 0.00
Earnings Per Share-Unit Curr -2.95 -4.34 -7.71 -1.06 5.60 0.89
Earnings Per Share(Adj)-Unit Curr -2.95 -4.34 -7.71 -1.06 5.60 0.89
Book Value 16.36 19.30 23.61 31.51 39.07 34.78
Book Value(Adj)-Unit Curr 16.36 19.30 23.61 31.51 39.07 34.78

Shareholding Pattern

  • Promoter Group

    53.65%

  • Public Share Holding

    46.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 26,879,650 53.65 26,879,650 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 26,879,650 53.65 26,879,650 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 447,924 0.89 447,924 94
Clearing Members 59,571 0.12 59,571 13
Directors of their Relatives 41,225 0.08 41,225 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 441,016 0.88 440,066 307
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,170,448 2.34 1,170,448 591
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,172,958 10.33 5,172,958 112
Individuals holding nominal share capital up to Rs. 1 lakh 15,888,436 31.71 15,885,665 26,581
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 11 0.00 11 1
Others 0 0.00 0 0
Sub Total 23,221,589 46.35 23,217,868 27,701
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 50,101,239 100.00 50,097,518 27,702

Company Background

Lasa Supergenerics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lasa Supergenerics Ltd
  • BSE Code : 67941.0
  • ISIN : INE670X01014

  • Incorporation Year

    2016

  • Registered Office

    C-105 MIDC
    Mahad, Raigad,
    Maharashtra-402301

  • Telephone

    91-2145-232101/232202

  • FAX

  • Chairman

    Omkar P Herlekar

  • Managing Director

  • Company Secretary

  • Auditor

    Gupta Rustagi & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Lasa Supergenerics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lasa Supergeneri 6.95 147.46 142.45 -1.02 0.00
Abbott India 27,784.15 7,217.19 6,929.05 38.04 43.78
Astrazeneca Phar 8,103.65 2,304.07 2,275.58 108.03 27.86
P & G Health Ltd 6,597.45 944.52 934.17 33.50 71.75
Glaxosmi. Pharma 2,653.45 3,932.76 3,790.20 44.42 58.17
Cipla 1,472.95 20,102.60 18,979.95 38.71 13.88
Amrutanjan Healt 515.00 469.50 451.82 25.71 21.89
Fermenta Biotec. 501.25 474.15 450.25 22.95 18.77
Bliss GVS Pharma 467.40 773.53 729.81 51.25 12.51
Guj. Themis Bio. 358.85 152.47 150.80 83.84 27.21
Ambalal Sarabhai 34.87 19.52 3.94 24.38 6.77